Investigational Site Number 792003

Izmir 35360

0 studies enrolling now · 4 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerotic Cardiovascular Disease, Diffuse Large B-cell Lymphoma

Studies at this site

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed